Iran’s medicine and infant-formula stocks average less than two months, with as many as 800 drug lines at risk of shortage within three months, industry representatives said, citing four-to-five-month delays in foreign-exchange allocation. https://t.co/XODhMEYL5z https://t.co/QpDZjWQuA1